Open access

222-B Critical clinical evaluation of plasma to tumor tissue concordance by cancer type using Illumina’s cell-free ctTSO500 commercial liquid biopsy assay
Rupesh Kanchi Ravi, Phillip Stafford, Hanlin (Harry) Gao, Jakub Sram, John Gao, Mickey Li, Erica Trinh

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 2) A1768; DOI: 10.1136/jitc-2023-SITC2023.0222-B
222-C A disruptive set of tools to realize the promise of the genomics revolution
Beverly Packard, Akira Komoriya

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 2) A1769; DOI: 10.1136/jitc-2023-SITC2023.0222-C
222-D Automated hyperplex staining and imaging system on various cancer tissues using off the shelf antibodies
Li Yen Chong, Felicia Wee, Jeffrey Lim, Craig Joseph, Zhen Wei Neo, Jia Ying Joey Lee, Lit-Hsin Loo, Joe Yeong

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 2) A1770-A1771; DOI: 10.1136/jitc-2023-SITC2023.0222-D
222-E Integrative spatial multi-omics analysis of NSCLC tumor microenvironment identifies key features associated with response to immune checkpoint inhibitor therapy
Steve Hamel, Marie Cumberbatch, Alexandro E Trevino, Ying Qu, Milan Bhagat, Meredith Manuel, Aaron Mayer

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 2) A1772; DOI: 10.1136/jitc-2023-SITC2023.0222-E
222-F Antibody labeling reagents to rapidly screen for the binding and internalization of therapeutic antibodies
Ryan Holly, Chris Langsdorf

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 2) A1773-A1774; DOI: 10.1136/jitc-2023-SITC2023.0222-F
222-G Beyond PD-L1: unraveling the enigma of immunotherapy response in PD-L1 negative (<1%) NSCLC patients through quantification of PD-1/PD-L1 engagement in the tumor microenvironment
Juan Gumuzio, Lissete Sanchez-Magraner, James Miles, Fernando Aguirre, Peter J Parker, Veronique Calleja

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 2) A1775; DOI: 10.1136/jitc-2023-SITC2023.0222-G
222-H A single-cell spatial cancer atlas of solid malignancies
Colles Price, Kazuho Nishimura, Michael Zhou, Som Bandyopadhyay, Russell Weiner, Darrell Borger

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 2) A1776; DOI: 10.1136/jitc-2023-SITC2023.0222-H
222-I A single-domain antibody-based PET tracer to visualize human CD4-positive cells in vivo
Bjoern Traenkle

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 2) A1777; DOI: 10.1136/jitc-2023-SITC2023.0222-I
222-J Longitudinal spatial profiling of pediatric high-grade glioma reveals a heterogeneous and dynamic immune microenvironment with therapeutic implications
Abigail M Zellmer, Jonathan Sussman, Amy E Baxter, Rami S Vanguri, Kyung Jin Ahn, Arianne Parvaresh-Rizi, Anusha Thadi, Chia-hui Chen, Wenbao Yu, Kristina Cole, Kai Tan, Derek A Oldridge

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 2) A1778; DOI: 10.1136/jitc-2023-SITC2023.0222-J
222-K Integrated immunoprofiling and RNA sequencing (RNA-seq) for anti-PD-1 response prediction in head and neck squamous cell carcinomas (HNSCC)
Anastasia Nikitina, Alexander Zaytcev, Jennifer Johnson, Eric Mastrolonardo, Madalina Tuluc, Alban J Linnenbach, Anastasia Sobol, Tatiana Vasileva, Arseniy Sokolov, Daniiar Dyikanov, Evgeniia Alekseeva, Andrey Tyshevich, Vladimir Kushnarev, Christopher JH Davitt, Michael F Goldberg, Cagdas Tazearslan, Adam J Luginbuhl, Alexander Bagaev

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 2) A1779-A1781; DOI: 10.1136/jitc-2023-SITC2023.0222-K

Main menu

Open access

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Open access

Pages